Compile Data Set for Download or QSAR
maximum 50k data
Found 105 Enz. Inhib. hit(s) with all data for entry = 50036426
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM499(6-hexyl-3-[(6-hexyl-4,7-dihydroxy-2-oxo-3,4-dihydr...)
Affinity DataIC50:  320nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM502(2-({4-[bis(3-hydroxy-1,4-dioxo-1,4-dihydronaphthal...)
Affinity DataIC50:  750nMAssay Description:Inhibitory activity against HIV-1 Protease.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM506(3-({4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]...)
Affinity DataIC50:  800nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 2)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM506(3-({4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]...)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibitory activity against HIV-2 Integrase was measured using 3'-processing (3'-proc) assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM506(3-({4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]...)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM506(3-({4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]...)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibitory activity against HIV-1 Protease.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM502(2-({4-[bis(3-hydroxy-1,4-dioxo-1,4-dihydronaphthal...)
Affinity DataIC50:  2.70E+3nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051629(2-(4-Chloro-benzyl)-3-hydroxy-[1,4]naphthoquinone ...)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM502(2-({4-[bis(3-hydroxy-1,4-dioxo-1,4-dihydronaphthal...)
Affinity DataIC50:  7.50E+3nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051633(2-[3-(Decahydro-naphthalen-2-yl)-propyl]-3-hydroxy...)
Affinity DataIC50:  8.50E+3nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA topoisomerase 1(Homo sapiens (Human))
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM506(3-({4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]...)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibitory activity against topoisomerase I.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM499(6-hexyl-3-[(6-hexyl-4,7-dihydroxy-2-oxo-3,4-dihydr...)
Affinity DataIC50:  1.05E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM499(6-hexyl-3-[(6-hexyl-4,7-dihydroxy-2-oxo-3,4-dihydr...)
Affinity DataIC50:  1.20E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM514(4-hydroxy-3,8-diphenyl-2H-chromen-2-one | Cancer C...)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM505(3-[2H-1,3-benzodioxol-5-yl(4-hydroxy-2-oxo-2H-chro...)
Affinity DataIC50:  1.80E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051645(2-[3-bromo-4-hydroxy-5-methoxyphenyl(3-hydroxy-1,4...)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM500(4-hydroxy-3-[(4-hydroxy-2-oxo-3,4-dihydro-2H-1-ben...)
Affinity DataIC50:  2.10E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM508(2-[(2,4-dichlorophenyl)(3-hydroxy-1,4-dioxo-1,4-di...)
Affinity DataIC50:  2.40E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM505(3-[2H-1,3-benzodioxol-5-yl(4-hydroxy-2-oxo-2H-chro...)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM516(CHEMBL62658 | N-[2,6-bis(propan-2-yl)phenyl]-6-(4-...)
Affinity DataIC50:  3.10E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051645(2-[3-bromo-4-hydroxy-5-methoxyphenyl(3-hydroxy-1,4...)
Affinity DataIC50:  3.20E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM515(4-hydroxy-3-phenyl-2H-chromen-2-one | Cancer Chemo...)
Affinity DataIC50:  3.20E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051634(2-Heptylamino-3-hydroxy-[1,4]naphthoquinone | CHEM...)
Affinity DataIC50:  3.30E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM508(2-[(2,4-dichlorophenyl)(3-hydroxy-1,4-dioxo-1,4-di...)
Affinity DataIC50:  3.70E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM508(2-[(2,4-dichlorophenyl)(3-hydroxy-1,4-dioxo-1,4-di...)
Affinity DataIC50:  4.00E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM505(3-[2H-1,3-benzodioxol-5-yl(4-hydroxy-2-oxo-2H-chro...)
Affinity DataIC50:  4.70E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051619(2-hydroxy-3-[3-hydroxy-1,4-dioxo-1,4-dihydro-2-nap...)
Affinity DataIC50:  4.80E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051630(2-(4-Chloro-phenylsulfanylmethyl)-3-hydroxy-[1,4]n...)
Affinity DataIC50:  5.00E+4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051642(2-[3,4-dichlorophenyl(3-hydroxy-1,4-dioxo-1,4-dihy...)
Affinity DataIC50:  5.20E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051629(2-(4-Chloro-benzyl)-3-hydroxy-[1,4]naphthoquinone ...)
Affinity DataIC50:  5.60E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051635(Bis-(3-hydroxy-1,4-dioxo-1,4-dihydro-naphthalen-2-...)
Affinity DataIC50:  6.00E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA topoisomerase 1(Homo sapiens (Human))
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM502(2-({4-[bis(3-hydroxy-1,4-dioxo-1,4-dihydronaphthal...)
Affinity DataIC50:  6.00E+4nMAssay Description:Inhibitory activity against topoisomerase I.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051619(2-hydroxy-3-[3-hydroxy-1,4-dioxo-1,4-dihydro-2-nap...)
Affinity DataIC50:  6.80E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051617(2-hydroxy-3-[1-(3-hydroxy-1,4-dioxo-1,4-dihydro-2-...)
Affinity DataIC50:  7.20E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051643(CHEMBL309934 | N-{4-[Bis-(3-hydroxy-1,4-dioxo-1,4-...)
Affinity DataIC50:  7.80E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM500(4-hydroxy-3-[(4-hydroxy-2-oxo-3,4-dihydro-2H-1-ben...)
Affinity DataIC50:  8.00E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051641(2-hydroxy-3-[1-(3-hydroxy-1,4-dioxo-1,4-dihydro-2-...)
Affinity DataIC50:  8.30E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051643(CHEMBL309934 | N-{4-[Bis-(3-hydroxy-1,4-dioxo-1,4-...)
Affinity DataIC50:  8.60E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051642(2-[3,4-dichlorophenyl(3-hydroxy-1,4-dioxo-1,4-dihy...)
Affinity DataIC50:  9.00E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051641(2-hydroxy-3-[1-(3-hydroxy-1,4-dioxo-1,4-dihydro-2-...)
Affinity DataIC50:  9.00E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051635(Bis-(3-hydroxy-1,4-dioxo-1,4-dihydro-naphthalen-2-...)
Affinity DataIC50:  9.20E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051629(2-(4-Chloro-benzyl)-3-hydroxy-[1,4]naphthoquinone ...)
Affinity DataIC50:  9.20E+4nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM35538(CHEMBL81697 | symmetric dicoumarol analogue, 14)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051646(2-[4-chlorophenyl(3-hydroxy-1,4-dioxo-1,4-dihydro-...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM514(4-hydroxy-3,8-diphenyl-2H-chromen-2-one | Cancer C...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM515(4-hydroxy-3-phenyl-2H-chromen-2-one | Cancer Chemo...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051633(2-[3-(Decahydro-naphthalen-2-yl)-propyl]-3-hydroxy...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051615(CHEMBL84281 | NSC-280795 | Thiobenzoic acid S-(4-h...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051625(3-(4-Chloro-benzenesulfonyl)-4-hydroxy-7-methoxy-c...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrase(Human immunodeficiency virus 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50051644(2-[4-dimethylaminophenyl(3-hydroxy-1,4-dioxo-1,4-d...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: